SFA
TEVA icon

Souders Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Souders Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-83,821
Closed -$830K – 142
2021
Q2 		$830K Buy
83,821
+9,869
+13% +$104K 0.28% 76
2021
Q1 		$853K Buy
73,952
+4,799
+7% +$55K 0.33% 64
2020
Q4 		$667K Buy
69,153
+4,651
+7% +$44.6K 0.29% 67
2020
Q3 		$621K Buy
64,502
+4,925
+8% +$52.1K 0.29% 66
2020
Q2 		$735K Buy
59,577
+16,216
+37% +$183K 0.42% 55
2020
Q1 		$389K Buy
+43,361
New +$444K 0.34% 65

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Souders Financial Advisors's TEVA Position: Q3 2021 in Review

Souders Financial Advisors sold out of Teva Pharmaceuticals (TEVA) in Q3 2021, closing a stake of 83,821 shares — an estimated $830K sold.

Souders Financial Advisors first reported a position in TEVA in Q1 2020 and held it in 6 quarters. The position peaked at $853K in Q1 2021. 429 funds tracked by Wall St. Rank hold TEVA as of Q3 2021.

  • Souders Financial Advisors reported no remaining Teva Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Souders Financial Advisors sold 83,821 Teva Pharmaceuticals shares in Q3 2021, an estimated $830K.
  • Souders Financial Advisors first reported a position in Teva Pharmaceuticals in Q1 2020 and held it in 6 quarters.
  • Souders Financial Advisors's Teva Pharmaceuticals position peaked at $853K in Q1 2021.
  • 429 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2021.

Based on Souders Financial Advisors's 13F filing for Q3 2021, filed 3 Nov 2021.